HPCM
BBH icon

Hunter Perkins Capital Management’s VanEck Biotech ETF BBH Stock Holding History

Hunter Perkins Capital Management’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,279
Closed -$556K – 92
2020
Q4 		$556K Buy
+3,279
New +$540K 0.1% 110

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Hunter Perkins Capital Management's BBH Position: Q1 2021 in Review

Hunter Perkins Capital Management sold out of VanEck Biotech ETF (BBH) in Q1 2021, closing a stake of 3,279 shares — an estimated $556K sold.

Hunter Perkins Capital Management first reported a position in BBH in Q4 2020 and held it in 1 quarter. The position peaked at $556K in Q4 2020. 105 funds tracked by Wall St. Rank hold BBH as of Q1 2021.

  • Hunter Perkins Capital Management reported no remaining VanEck Biotech ETF position as of Q1 2021 after selling out during the quarter.
  • Hunter Perkins Capital Management sold 3,279 VanEck Biotech ETF shares in Q1 2021, an estimated $556K.
  • Hunter Perkins Capital Management first reported a position in VanEck Biotech ETF in Q4 2020 and held it in 1 quarter.
  • Hunter Perkins Capital Management's VanEck Biotech ETF position peaked at $556K in Q4 2020.
  • 105 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2021.

Based on Hunter Perkins Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.